Benefits
Blood pressure support
Three pooled analyses of 8 to 10 small randomized trials found systolic pressure about 5.6 to 7.9 mmHg lower with chia, but one review rated most studies low quality and an earlier review of 12 trials rated the certainty low or very low. In a 12-week trial of 50 g/day in 76 overweight adults, blood pressure did not differ from placebo.
Smaller rise in blood sugar after a meal
In single-meal tests in 13 to 15 healthy adults, 7 to 25 g of chia baked into bread or stirred into a glucose drink lowered the 2-hour rise in blood sugar, more so at higher amounts. Over weeks it is a different picture: a pooled analysis of 8 trials found no change in fasting glucose, HbA1c or insulin.
Plant omega-3 (ALA) intake
Close to 60% of chia's fat is ALA, about 4.5 g per 25 g serving. Eating chia daily raised blood ALA in trials. In a 10-week trial, milled chia also raised EPA while the same amount of whole seed did not significantly change either one. DHA, the main omega-3 in fish oil, did not rise, so chia does not stand in for fish oil.
Appetite and fullness after eating
In a crossover study in 24 adults, a yogurt snack with 7 or 14 g of chia reduced hunger and the amount eaten at lunch, and in a glucose-drink test chia lowered appetite ratings more than flax. These were one-day effects. Pooled trials found no change in body weight, and one 6-month diet trial found about 1.6 kg more loss than control.
Cholesterol and triglyceride levels
A pooled analysis of 10 randomized trials found no statistically significant change in total cholesterol, LDL, HDL or triglycerides with chia. Two other analyses found a small drop in HDL, often called the good cholesterol. Chia supplies ALA and fiber, but it should not be counted on to improve a lipid panel.
Mechanism of action
Gel-forming fiber
Chia's soluble fiber swells into a thick gel in liquid. In lab testing a chia drink was about 20 times more viscous than a flax drink, and the researchers proposed that this thicker gel releases sugar from a meal more slowly, which would fit the smaller post-meal blood sugar rise and lower appetite seen in single-meal tests.
Omega-3 ALA
Eating chia raises blood ALA, and in two trials EPA rose as well, but DHA did not rise in the chia trials that measured it. How much of any blood pressure effect comes from ALA, fiber or minerals has not been worked out.
Milling breaks the seed coat
Grinding the seed changes what the body gets from it. In a 10-week trial, milled chia raised blood ALA and EPA while the same amount of whole seed did not significantly change them. For the post-meal blood sugar effect, however, whole and ground seed baked into bread worked equally well.
Clinical trials
Single-blind randomized crossover trial of 37 g/day Salba chia versus wheat bran for 12 weeks each, added to usual diabetes treatment (Vuksan et al. 2007, Diabetes Care).
20 adults with well-controlled type 2 diabetes (average age 64) in Toronto, Canada.
Compared with wheat bran, chia lowered systolic blood pressure by about 6.3 mmHg and lowered hs-CRP and von Willebrand factor, markers linked to inflammation and blood clotting. Plasma ALA and EPA roughly doubled. Body weight and liver, kidney and clotting tests did not change. Very small, single-blind, and done in people already under medical care.
Single-blind randomized placebo-controlled trial of 25 g chia in water twice daily before the first and last meal for 12 weeks (Nieman et al. 2009, Nutr Res).
90 overweight or obese men and women aged 20 to 70 without diagnosed disease; 76 completed (39 chia, 37 placebo).
Plasma ALA rose 24.4% on chia versus a 2.8% fall on placebo. Body weight, body fat, inflammation and oxidative stress markers, blood pressure and blood lipids did not differ from placebo, and changes in EPA and DHA did not differ from placebo.
Double-blind randomized trial of 25 g/day whole chia, milled chia or a poppy seed placebo for 10 weeks (Nieman et al. 2012, J Altern Complement Med).
62 overweight postmenopausal women aged 49 to 75; 56 completed (14 milled, 16 whole, 26 placebo).
Milled chia raised plasma ALA by 58% and EPA by 39%; whole chia did not change them significantly. Neither form changed body composition, blood pressure, arterial stiffness (augmentation index), inflammation markers or blood lipids compared with placebo.
Randomized crossover dose-response test of 7, 15 or 24 g of whole or ground Salba chia baked into white bread against matched control breads, with blood sugar measured over 2 hours (Ho et al. 2013, Eur J Clin Nutr).
13 healthy adults (6 men, 7 women), each tested on nine occasions.
The blood sugar response fell as the chia dose rose, and whole and ground seed worked equally well. No adverse events were reported. These were single-meal tests, so they do not show what happens with regular use.
Randomized crossover trial of a mid-morning yogurt with 0, 7 or 14 g of chia, followed by a self-serve lunch (Ayaz et al. 2017, Nutr Res Pract).
24 adults, in a study run at Hacettepe University in Ankara, Turkey.
On the chia days, people reported less hunger, less desire for sugary foods and more fullness, and ate less at lunch. The effect was measured over a single morning; body weight was not studied.
Double-blind randomized trial of Salba chia (30 g per 1000 kcal per day) versus an oat bran control, both alongside a 6-month calorie-reduced diet (Vuksan et al. 2017, Nutr Metab Cardiovasc Dis).
77 overweight or obese adults with type 2 diabetes (HbA1c 6.5 to 8.0%).
The chia group lost 1.9 kg versus 0.3 kg on control, with a larger drop in waist size (3.5 vs 1.1 cm) and in C-reactive protein, and a rise in adiponectin. The weight difference is small and came alongside a reduced-calorie diet; the 12-week placebo-controlled trial of chia without a diet found no weight change.
Systematic review and dose-response meta-analysis of randomized controlled trials published up to August 2023 (TaghipourSheshdeh et al. 2025, Nutr Rev).
Adults across 8 randomized trials.
Chia lowered systolic blood pressure by about 7.2 mmHg and diastolic by about 6.0 mmHg; in subgroups the systolic effect was significant in people starting below 140 mmHg and did not depend on dose. Body weight, body fat, waist, BMI, fasting glucose and HbA1c did not change. The authors caution that the data are few.